Xtant Medical Holdings XTNT Gain (Loss) on Disposition of Stock in Subsidiary
Gain (Loss) on Disposition of Stock in Subsidiary at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:GainOrLossOnSaleOfStockInSubsidiary.
The official record: Xtant Medical Holdings’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's gain (loss) on disposition of stock in subsidiary.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xtant Medical Holdings's gain (loss) on disposition of stock in subsidiary?
- Xtant Medical Holdings (XTNT) reported gain (loss) on disposition of stock in subsidiary of $820.25K in Q4 2025.
- What does gain (loss) on disposition of stock in subsidiary mean?
- The net profit or loss realized from the sale of equity interests in a subsidiary or business unit. This is classified as an operating adjustment to remove the non-recurring impact of divestiture gains or losses from core operating cash flow. It allows investors to distinguish between cash generated from ongoing business activities and cash generated from corporate restructuring.